ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,359Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 2056

$534K Total Retail Price of All Prescriptions

Rank: 54 out of 2056

459 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 459 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

23% of this provider’s 459 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 7,777 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
HYDROCODONE-ACETAMINOPHEN 519 322 S3 1 5
LISINOPRIL 504 456 2 1
LEVOTHYROXINE SODIUM 454 380 3 3
OMEPRAZOLE 321 199 4 4
AMLODIPINE BESYLATE 270 238 5 6
METFORMIN HCL 269 219 6 8
PRAVASTATIN SODIUM 258 206 7 20
SIMVASTATIN 249 221 8 2
FUROSEMIDE 237 186 9 9
GABAPENTIN 197 142 10 14
HYDROCHLOROTHIAZIDE 191 173 11 7
DOXAZOSIN MESYLATE 175 175 12 76
ATENOLOL 158 128 13 10
METOPROLOL TARTRATE 150 125 14 11
WARFARIN SODIUM 149 132 15 12
LOSARTAN POTASSIUM 138 120 16 13
TAMSULOSIN HCL 120 101 17 28
ATORVASTATIN CALCIUM 117 102 18 17
ZOLPIDEM TARTRATE 108 71 19 23
CITALOPRAM HBR 102 69 20 15
LOVASTATIN 102 80 20 16
CARISOPRODOL 96 21 R 22 97
PROAIR HFA 90 64 23 29
ALLOPURINOL 88 68 24 32
METOPROLOL SUCCINATE 85 82 25 19
RANITIDINE HCL 84 51 26 22
SERTRALINE HCL 80 61 27 25
LYRICA 79 14 28 124
OXYBUTYNIN CHLORIDE 79 60 28 79
MIRTAZAPINE 79 69 28 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 63 31 34
OXYCODONE HCL-ACETAMINOPHEN 77 34 S2 31 111
ALENDRONATE SODIUM 76 69 33 26
POTASSIUM CHLORIDE 76 71 33 18
CYMBALTA 75 43 35 59
MORPHINE SULFATE ER 74 39 S2 36 36
TRAMADOL HCL 70 52 37 27
METHOCARBAMOL 68 18 R 38 65
AMITRIPTYLINE HCL 67 53 R 39 60
AZITHROMYCIN 65 49 40 54
DONEPEZIL HCL 65 61 40 37
CARVEDILOL 64 53 42 35
LOSARTAN-HYDROCHLOROTHIAZIDE 63 60 43 78
GLIPIZIDE 62 52 44 39
FAMOTIDINE 61 49 45 89
VERAPAMIL ER 59 58 46 128
PRAMIPEXOLE DIHYDROCHLORIDE 58 16 47 143
PANTOPRAZOLE SODIUM 57 53 48 55
CYCLOBENZAPRINE HCL 57 27 R 48 52
ESTRADIOL 55 43 R 50 85
GLIPIZIDE XL 55 51 50 159
OXYCODONE HCL 55 19 S2 50 24
PREDNISONE 54 49 53 38
CLOPIDOGREL 52 43 54 72
SPIRIVA 50 32 55 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.